Back

Blood Advances

16 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
2026-03-02 hematology 10.64898/2026.02.22.26346823
Top 0.1% (18.1%)
Show abstract

Allogeneic hematopoietic cell transplantation (allo-HCT) hinges on a delicate trade-off between graft-versus-tumor control and graft-versus-host disease (GvHD), mediated by donor T-cell recognition of antigens presented by recipient human leukocyte antigen (HLA) molecules. We hypothesized that, beyond allele-level matching, sequence divergence at peptide-binding grooves across donor and recipient HLA loci shapes these responses. To this end, we evaluated the effect of HLA evolutionary divergence...

2
Development and Internal Validation of the AB-IPI using Bootstrapping: A Clinicopathological Prognostic Score Integrating Host Fitness and Tumor Biology in Diffuse Large B-Cell Lymphoma
2026-02-19 hematology 10.64898/2026.02.18.26346527
Top 0.1% (18.1%)
Show abstract

ObjectivesThe therapeutic efficacy of rituximab has reduced the discriminatory power of the International Prognostic Index (IPI) in diffuse large B-cell lymphoma (DLBCL), particularly within intermediate-risk categories. To address this "risk dilution," we aimed to develop and internally validate the AB-IPI (Albumin-BCL2 Refined Prognostic Index) using a hypothesis-driven approach that integrates tumor burden, host fitness, and tumor biology. MethodsThis multi-center retrospective study analyze...

3
A Definitive Tcrbeta1/ Tcrbeta2 Antibody Pair For Determining T-Cell Monotypia As A Surrogate For Clonality In Lymphoma Diagnosis In Formalin Fixed Paraffin Embedded Material
2026-02-17 pathology 10.64898/2026.02.13.26346202
Top 0.2% (17.5%)
Show abstract

T-cell lymphomas are often histologically indistinguishable from benign T-cell infiltrates. Clonality testing is frequently required for diagnosis. It lacks the spatial context and is slow and expensive, relying on complex, multiplexed PCR reactions, interpreted by experienced scientists or pathologists. We previously published details of a pair of highly specific monoclonal antibodies against the two alternatively used, but very similar, T-cell receptor {beta} constant regions, TCR{beta}1 and T...

4
Plasma proteome signatures in sickle cell anaemia and effect of hydroxyurea treatment
2026-02-10 hematology 10.64898/2026.02.08.26345875
Top 0.2% (13.9%)
Show abstract

BackgroundSickle Cell Anaemia (SCA), a genetic blood disorder caused by a single mutation in the beta globin gene, displays a highly variable clinical course. Hydroxyurea (HU), an effective treatment, has an unclear mechanism of action. Plasma proteins can act as biomarkers for understanding disease states and response to HU treatment in SCA patients. MethodsPlasma proteome profiling of 31 healthy individuals and 76 SCA patients, including those with and without HU treatment, was performed usin...

5
Substance P, mast cells and basophils are involved in acute chest syndrome in sickle cell disease
2026-03-03 hematology 10.64898/2026.03.02.26347450
Top 0.3% (9.0%)
Show abstract

A role for substance P in promoting neurogenic inflammation and pain has been described in sickle cell disease (SCD). However its origin and contribution to SCD pathophysiology remain unclear. We measured substance P level in plasma from 225 patients with SCD and observed the highest concentrations during acute chest syndrome (ACS). Therefore, we tested the hypothesis that substance P may induce ACS. In transgenic sickle mice, unlike control mice, intravenous injection of substance P caused leth...

6
Systems Biology and Machine Learning Decode an Immunometabolic Signature for Post-Thrombotic Syndrome
2026-02-11 hematology 10.64898/2026.02.09.26345941
Top 0.4% (7.7%)
Show abstract

ObjectivePost-thrombotic syndrome (PTS), a common complication of deep vein thrombosis, lacks objective diagnostic biomarkers and its molecular mechanisms remain poorly understood. This study aimed to identify plasma biomarkers and clarify pathways using integrated multi-omics and machine learning. MethodsProteomic and metabolomic profiling of 75 PTS patients and 75 controls was performed. Differential expression analysis, pathway enrichment, and protein-metabolite network analysis were conduct...

7
Genetic insights into immunothrombosis: from shared loci to repurposed drugs for autoimmune and thrombotic diseases
2026-03-03 hematology 10.64898/2026.02.28.26346627
Top 0.4% (6.6%)
Show abstract

ObjectiveAutoimmune diseases (ADs) markedly elevate venous thromboembolism (VTE) risk, yet the shared genetic architecture and tissue-specific regulatory mechanisms of this "Autoimmune-Thrombotic Axis" remain poorly defined. We aimed to characterize the genomic landscape of immunothrombosis to identify causal links and therapeutic targets. Approach and ResultsWe integrated large-scale GWAS data for VTE and 16 ADs using a multi-omics framework, including pleiotropy scanning, local genetic correl...

8
The Efficacy and Safety of Daily Low-Dose Iron Supplementation in Adults with Dietary Iron Deficiency: a Double-Blind, Randomized, Single-Center Study
2026-02-26 hematology 10.64898/2026.02.24.26346946
Top 0.4% (6.5%)
Show abstract

Iron deficiency (ID) is the most common nutritional deficiency worldwide, often caused by insufficient dietary intakes. Oral supplementation is one of the means to improve iron status. This study evaluated the efficacy and safety of two low-dose iron supplements - >Your< Iron Forte Capsules (YIFC) and Ferrous Sulfate Capsules (FSC) - in individuals with dietary ID. One hundred and one participants (mean age 30.6 years; 98% women) with low iron stores (mean serum ferritin 16.1 {micro}g/L) were ra...

9
Anthracycline-mediated cardiac dysfunction: An endothelial perspective
2026-03-04 cardiovascular medicine 10.64898/2026.03.02.26347478
Top 0.8% (1.5%)
Show abstract

BackgroundAnthracyclines are central to childhood cancer therapy but predispose patients to cardiotoxicity leading to long-term cardiovascular risk. Endothelial injury and impaired repair contribute to this, yet pediatric data remain limited. ObjectiveTo longitudinally assess endothelial injury and repair in childhood cancer patients treated with anthracyclines by quantifying circulating endothelial cells (CECs) and endothelial progenitor cells (EPCs). MethodsIn a single-centre retrospective c...

10
Reprogramming of the Sepsis N-Glycoproteome Illuminates a Functional Dissociation between Protein Abundance and Glycosylation in Immunothrombosis
2026-02-11 intensive care and critical care medicine 10.64898/2026.02.09.26345940
Top 0.8% (1.4%)
Show abstract

PurposeSepsis-associated immunothrombosis significantly contributes to high mortality, yet the role of N-glycosylation in this process remains poorly understood. This study aimed to comprehensively profile the plasma N-glycosylation landscape in sepsis and elucidate how its specific reprogramming in the complement and coagulation cascades influences immunothrombotic balance and patient outcomes. MethodsWe performed in-depth 4D-DIA proteomic and N-glycomic analyses on plasma from 43 sepsis patie...

11
A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation
2026-02-11 oncology 10.64898/2026.02.10.26345949
Top 0.8% (1.3%)
Show abstract

Allogeneic hematopoietic cell transplantation is the only curative option for many patients with acute myeloid leukemia (AML). In the current study, we designed and implemented a personalized assay, called v96, incorporating up to 96 mutations in 30 AML patients undergoing transplantation. The assay was performed on DNA derived in cells from the bone marrow as well as in cell-free plasma. All 30 (100%) of patients harbored molecular evidence of residual leukemia during remission that was detecta...

12
Low Dose Naltrexone Prescribing Practices for Children and Adolescents with Long COVID
2026-02-22 pediatrics 10.64898/2026.02.20.26346719
Top 0.8% (1.3%)
Show abstract

BackgroundPediatric long COVID is associated with substantial symptom burden, yet evidence-based pharmacologic treatments remain limited. Low-dose naltrexone (LDN) has been proposed as a potential symptomatic therapy, but data in pediatric populations is lacking. MethodsWe conducted a retrospective analysis of pediatric and young adult patients ([&le;]25 years) with a clinical diagnosis of long COVID who were prescribed LDN between July 2020 and July 2025 at three multidisciplinary pediatric lo...

13
Early Detection of CAR-T-Associated Neurotoxicity via Cytokine Monitoring in Serum
2026-03-04 oncology 10.64898/2026.03.03.26347491
Top 0.8% (1.3%)
Show abstract

Immune effector cell-associated neurotoxicity syndrome (ICANS) is a common and life-threatening complication of chimeric antigen receptor (CAR) T-cell therapy, with early detection being critical for timely intervention and improved outcomes. Cytokines such as interleukin-6 (IL-6) are key mediators of the inflammatory cascade underlying ICANS pathogenesis, but prospective clinical evidence for their predictive value is limited. Here we quantify IL-6 levels in a prospective cohort of 40 CAR-T pat...

14
Morphological set enrichment enables interpretable prognostication and molecular profiling of meningiomas
2026-02-24 pathology 10.64898/2026.02.23.26346491
Top 1% (0.7%)
Show abstract

Meningiomas are the most common primary brain tumors and, despite their benign reputation, often behave aggressively. Meningiomas are morphologically heterogeneous, yet the full significance of their histologic diversity is unclear. This is in large part because many features are not readily quantifiable by traditional observer-based light microscopy. Molecular testing improves prognostic stratification, but is not universally accessible. We therefore sought to determine whether an artificial in...

15
Active concentration of de novo anti-HLA-DQ donor specific antibodies measured by surface plasmon resonance is associated with chronic lung allograft dysfunction
2026-02-14 transplantation 10.64898/2026.02.11.26344836
Top 1% (0.7%)
Show abstract

BackgroundIn lung transplantation, de novo immunodominant donor-specific anti-HLA antibodies recognizing HLA-DQ antigens (dn-iDSA-DQ) are predominant and can induce chronic lung allograft dysfunction (CLAD). We previously developed a method to measure the active concentration of dn-iDSA-DQ. We aimed to determine whether this new quantitative biomarker is associated with transplantation outcomes. MethodsThis retrospective multicentre cohort study included 90 lung transplant recipients (LTRs) dev...

16
Pretransplant and posttransplant erythroferrone levels and outcomes after heart transplantation
2026-02-24 transplantation 10.64898/2026.02.20.26346755
Top 1% (0.7%)
Show abstract

BackgroundIron metabolism disorder is highly prevalent before and after heart transplantation (HTx). The impact of pretransplant and posttransplant iron disorder on posttransplant outcomes is unclear. ObjectivePretransplant serum levels of key regulator proteins of iron metabolism (hepcidin, interleukin-6, erythroferrone) were tested for prediction of the composite outcome 1-year posttransplant all-cause mortality (ACM) or [&ge;]moderate acute cellular rejection (ACR). Furthermore, serum levels...

17
An Exploratory Study of Host Plasma Proteomic Signatures that Distinguish Active Syphilis in Adults
2026-03-05 infectious diseases 10.64898/2026.03.04.26347505
Top 1% (0.7%)
Show abstract

Syphilis remains a major public health concern. However, current serologic assays are limited in their ability to distinguish active from previously treated disease. We applied tandem mass tag-based quantitative proteomics to plasma from 10 adults with active syphilis and 10 age- and gender-matched non-diseased controls. We identified 54 differentially regulated proteins (36 upregulated, 18 downregulated). Those proteins map to immune and inflammatory responses, acute-phase signaling, coagulatio...

18
Deep Learning-Based Screening for POLE mutations on Histopathology Slides in Endometrial Cancer
2026-02-09 pathology 10.64898/2026.02.06.26345335
Top 1% (0.5%)
Show abstract

POLE sequencing for somatic mutations (POLEmut) guides adjuvant therapy in endometrial cancer (EC), but cost and infrastructural considerations lead to limited uptake. Omission of POLE testing leads to unnecessary exposure to radiotherapy and/or chemotherapy. We developed POLARIX, a multiple instance deep learning model with attention pooling, which predicts POLE mutation status from routine hematoxylin and eosin whole-slide images (WSIs). Trained on 2,238 cases from eleven EC cohorts, POLARIX s...

19
Integration of clinical and genomic data defines prognostic phenotypes in resected perihilar cholangiocarcinoma: a national multicenter study
2026-02-17 transplantation 10.64898/2026.02.16.26346384
Top 1% (0.5%)
Show abstract

Background & AimsPerihilar cholangiocarcinoma is an aggressive malignancy with clinical heterogeneity and poor long-term outcomes after resection. Current prognostic assessment relies mainly on anatomical staging and pathological features, which incompletely capture the entire postoperative risk. We aimed to determine whether integrative analysis of clinical, surgical, pathological and tumor genomic data could improve time-resolved, individualized recurrence-risk prediction after curative-intent...

20
SATB2/elastic lamina dual-staining in colon cancer: clinicopathological impact and prognostic value
2026-02-22 pathology 10.64898/2026.02.19.26346607
Top 1% (0.5%)
Show abstract

ObjectiveTo explore the application value of dual-staining for specific AT sequence binding protein 2 (SATB2) immunohistochemistry and elastic lamina in detecting elastic lamina invasion (ELI) in pT3 colon cancer, and to assess its association with clinicopathological characteristics, staging, and prognosis. MethodsThis retrospective cohort study enrolled 176 pT3 colon cancer patients who underwent radical resection at Affiliated Jinhua Hospital Zhejiang University School of Medicine. The deepe...